chrX-77785990-C-T

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_000489.6(ATRX):​c.12G>A​(p.Glu4Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000537 in 1,191,279 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 24 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000064 ( 0 hom., 3 hem., cov: 21)
Exomes 𝑓: 0.000053 ( 0 hom. 21 hem. )

Consequence

ATRX
NM_000489.6 synonymous

Scores

1
1

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.41

Publications

0 publications found
Variant links:
Genes affected
ATRX (HGNC:886): (ATRX chromatin remodeler) The protein encoded by this gene contains an ATPase/helicase domain, and thus it belongs to the SWI/SNF family of chromatin remodeling proteins. This protein is found to undergo cell cycle-dependent phosphorylation, which regulates its nuclear matrix and chromatin association, and suggests its involvement in the gene regulation at interphase and chromosomal segregation in mitosis. Mutations in this gene are associated with X-linked syndromes exhibiting cognitive disabilities as well as alpha-thalassemia (ATRX) syndrome. These mutations have been shown to cause diverse changes in the pattern of DNA methylation, which may provide a link between chromatin remodeling, DNA methylation, and gene expression in developmental processes. Multiple alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2017]
ATRX Gene-Disease associations (from GenCC):
  • alpha thalassemia-X-linked intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • ATR-X-related syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability-hypotonic facies syndrome, X-linked, 1
    Inheritance: XL Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant X-77785990-C-T is Benign according to our data. Variant chrX-77785990-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 533643.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.41 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 3 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATRXNM_000489.6 linkc.12G>A p.Glu4Glu synonymous_variant Exon 1 of 35 ENST00000373344.11 NP_000480.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATRXENST00000373344.11 linkc.12G>A p.Glu4Glu synonymous_variant Exon 1 of 35 1 NM_000489.6 ENSP00000362441.4 P46100-1

Frequencies

GnomAD3 genomes
AF:
0.0000641
AC:
7
AN:
109231
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000295
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00431
Gnomad NFE
AF:
0.0000571
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000142
AC:
21
AN:
147727
AF XY:
0.000198
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000370
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000810
Gnomad OTH exome
AF:
0.000259
GnomAD4 exome
AF:
0.0000527
AC:
57
AN:
1081999
Hom.:
0
Cov.:
31
AF XY:
0.0000596
AC XY:
21
AN XY:
352569
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25980
American (AMR)
AF:
0.000362
AC:
12
AN:
33143
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19059
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29265
South Asian (SAS)
AF:
0.000310
AC:
16
AN:
51689
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39317
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4116
European-Non Finnish (NFE)
AF:
0.0000324
AC:
27
AN:
833963
Other (OTH)
AF:
0.0000440
AC:
2
AN:
45467
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000641
AC:
7
AN:
109280
Hom.:
0
Cov.:
21
AF XY:
0.0000951
AC XY:
3
AN XY:
31540
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30032
American (AMR)
AF:
0.000294
AC:
3
AN:
10195
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2627
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3424
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2479
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5658
Middle Eastern (MID)
AF:
0.00474
AC:
1
AN:
211
European-Non Finnish (NFE)
AF:
0.0000571
AC:
3
AN:
52512
Other (OTH)
AF:
0.00
AC:
0
AN:
1481
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.000142
Hom.:
1
Bravo
AF:
0.0000945

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ATRX: BP4, BP7, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 16, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jan 05, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Alpha thalassemia-X-linked intellectual disability syndrome Benign:1
Jan 25, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.35
CADD
Benign
13
DANN
Uncertain
0.97
PhyloP100
1.4
PromoterAI
-0.043
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782765957; hg19: chrX-77041476; API